InsiderClue
Insiders · Profile

Cumbo Alexander

President and CEO at Solid Biosciences · EVP, Chief Commercial Officer at Sarepta Therapeutics. Filing since 20 Jul 2017. CIK 0001685994

SLDB Solid Biosciences Inc. President and CEO · 7 trades SRPT Sarepta Therapeutics, Inc. EVP, Chief Commercial Officer · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SLDB Solid Biosciences Inc.
18 Feb 2026
President and CEO
Sold on a plan
16,644
$96.92K
6.6%
SLDB Solid Biosciences Inc.
4 Feb 2026
President and CEO
Sold on a plan
48,913
$315.09K
18.1%
SLDB Solid Biosciences Inc.
2 Feb 2026
President and CEO
Sold on a plan
80,258
$516.61K
22.9%
SLDB Solid Biosciences Inc.
3 Dec 2025
President and CEO
Sold on a plan
10,808
$55.23K
11.7%
SLDB Solid Biosciences Inc.
14 Feb 2025
President and CEO
Sold on a plan
11,365
$45.01K
15.8%
SLDB Solid Biosciences Inc.
3 Dec 2024
President and CEO
Sold at will
11,114
$62.24K
22.4%
SLDB Solid Biosciences Inc.
4 Dec 2023
President and CEO
Sold at will
11,757
$32.52K
40.3%
SRPT Sarepta Therapeutics, Inc.
13 Dec 2019
EVP, Chief Commercial Officer
Sold, plan not stated
42,000
$5.27M
95.7%
SRPT Sarepta Therapeutics, Inc.
1 Feb 2019
SVP, Chief Commercial Officer
Sold, plan not stated
15,000
$2.10M
49.6%
SRPT Sarepta Therapeutics, Inc.
9 Jul 2018
SVP, Chief Commercial Officer
Sold, plan not stated
33,782
$4.64M
54.0%
SRPT Sarepta Therapeutics, Inc.
20 Jul 2017
SVP, Chief Commercial Officer
Sold, plan not stated
5,918
$242.64K
26.0%
11 decisions on file.